Clinical and microbiological evaluation of ventilator-associated pneumonia in an intensive care unit in Vietnam
- PMID: 38028362
- PMCID: PMC10679888
- DOI: 10.1016/j.infpip.2023.100318
Clinical and microbiological evaluation of ventilator-associated pneumonia in an intensive care unit in Vietnam
Abstract
Background: The increasing incidence of multidrug-resistant Gram-negative bacteria causing ventilator-associated pneumonia (VAP) is a global concern. A better understanding of the epidemiology of VAP in Southeast Asia is essential to optimise treatments and patient outcomes.
Methods: VAP epidemiology in an intensive care unit in Vietnam was investigated. A prospective cohort study was conducted. Patients who were ventilated for >48 hours, diagnosed with VAP, and had a positive respiratory culture between October 2015 and March 2017 were included. Whole-genome sequencing (WGS) was performed on Acinetobacter baumannii isolates.
Results: We identified 125 patients (137 episodes) with VAP from 1,699 admissions. Twelve patients had 2 VAP episodes. The median age was 60 years (interquartile range: 48-70), and 68.8% of patients were male. Diabetes mellitus was the most frequent comorbidity (N=35, 28%). Acinetobacter baumannii was most frequently isolated in the first VAP episode (N=84, 67.2%) and was multiply resistant to meropenem, levofloxacin, and amikacin. The 30-day mortality rate was 55.2% (N=69) and higher in patients infected with A. baumannii (N=52, 65%). WGS results suggested a complex spread of multiple clones.
Conclusions: In an intensive care unit in Vietnam, VAP due to A. baumannii had a high mortality rate, and A. baumannii and K. pneumoniae were multidrug resistant, with carbapenem resistance of 97% and 70%, respectively.
Keywords: Acinetobacter; Asia; Colistin; Healthcare-associated infection; ICU; Multidrug-resistant.
© 2023 The Authors.
Figures

References
-
- Weiner-Lastinger L.M., Pattabiraman V., Konnor R.Y., Patel P.R., Wong E., Xu S.Y., et al. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: A summary of data reported to the National Healthcare Safety Network. Infect Control Hosp Epidemiol. 2022;43:12–25. doi: 10.1017/ice.2021.362. - DOI - PubMed
-
- Weiner L.M., Webb A.K., Limbago B., Dudeck M.A., Patel J., Kallen A.J., et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol. 2016;37:1288–1301. doi: 10.1017/ice.2016.174. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases